Resignation of NZK Chair

17 April 2023


John Ryder steps down as Chair of NZK
New Zealand King Salmon Investments Limited (NZX & ASX: NZK) announced that John Ryder has informed the
Company of his intention to resign from his role as Chair. Mr Ryder’s resignation will take effect at the AGM
on the 14th of June 2023.

Mr Ryder became a Director of New Zealand King Salmon in 2009. Reflecting on his time serving on the Board
of New Zealand King Salmon, he said:

“It is the right time to leave NZKS, knowing the company is well-positioned for the future following the
recovery from disruptions caused by the Covid-19 pandemic and mortality event at the back end of FY22 and
start of FY23. The business has come a long way over the years, has an excellent team, a wonderful brand, and
has created a sound platform for the continual expansion of earnings. The board is due for a refresh, and I
wish to spend more time expanding my business activities with Qestral Corporation”.

Acting Chief Executive Graeme Tregidga said: “On behalf of New Zealand King Salmon I want to thank John for
his many contributions to the company during his 14-year tenure.”

Mr Ryder was the joint founder and joint CEO of Ryman Healthcare Limited and is currently Executive Chair of
Qestral Corporation and Independent Chair of Direct Capital VI Management Limited. Mr Ryder is a fellow of
the New Zealand Institute of Accountants and was inducted into the New Zealand Business Hall of Fame in
2021.

The Board will commence a search for a new Chair.

Ends

Contact

Graeme Tregidga, Acting CEO, New Zealand King Salmon Investments Ltd,
graeme.tregidga@kingsalmon.co.nz

Ben Rodgers, CFO and Company Secretary, New Zealand King Salmon Investments Ltd,
ben.rodgers@kingsalmon.co.nz